Conscience August 2025 Policy Brief - US Department of Health and Human Services (HHS) to gradually phase out funding for mRNA vaccine development.

The US Department of Health and Human Services (HHS) recently announced that it would gradually phase out funding for mRNA vaccine development. HHS Secretary, Robert F. Kennedy Jr., announced that nearly US$500 million will be cut from the Biomedical Advanced Research and Development Authority (BARDA)'s budget. Contracts with Emory University and Tiba Biotech will be ended, while mRNA-related work by Luminary Labs, ModeX, and Seqirus will be descoped. Proposals from Pfizer, Sanofi Pasteur, and Gritstone will also be rejected. Projects already in late-stage development will be allowed to continue. In all, 22 projects will be affected. This policy brief addresses how this development may effect the future of mRNA vaccine technology and human health.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-08-22
DOI
https://doi.org/10.5281/zenodo.16929041
Primary Topic
Geochemistry and Geologic Mapping
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Conscience August 2025 Policy Brief - US Department of Health and Human Services (HHS) to gradually phase out funding for mRNA vaccine development.

Zenodo (CERN European Organization for Nuclear Research)
Geochemistry and Geologic Mapping
article

Conscience August 2025 Policy Brief - US Department of Health and Human Services (HHS) to gradually phase out funding for mRNA vaccine development.

article en

Abstract

The US Department of Health and Human Services (HHS) recently announced that it would gradually phase out funding for mRNA vaccine development. HHS Secretary, Robert F. Kennedy Jr., announced that nearly US$500 million will be cut from the Biomedical Advanced Research and Development Authority (BARDA)'s budget. Contracts with Emory University and Tiba Biotech will be ended, while mRNA-related work by Luminary Labs, ModeX, and Seqirus will be descoped. Proposals from Pfizer, Sanofi Pasteur, and Gritstone will also be rejected. Projects already in late-stage development will be allowed to continue. In all, 22 projects will be affected. This policy brief addresses how this development may effect the future of mRNA vaccine technology and human health.

Zenodo (CERN European Organization for Nuclear Research)
McGill University (CA)
Partnerships for the goals
Openalex Percentile: Top 69%
Geochemistry and Geologic Mapping
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Conscience August 2025 Policy Brief - US Department of Health and Human Services (HHS) to gradually phase out funding for mRNA vaccine development. · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS